Epidemiological profile of cases and deaths of Severe Acute Respiratory Syndrome with emphasis on COVD-19 of Minas Gerais State Brazil 2021 to 2023
DOI:
https://doi.org/10.33448/rsd-v13i7.46349Keywords:
COVID-19; Severe acute respiratory syndrome; Descriptive study; SIVEP-Gripe; Minas Gerais.Abstract
The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, is a serious health problem on a global scale. The purpose of the research was to analyze the epidemiological profile of cases and deaths from Severe Acute Respiratory Syndrome (SARS), with a focus on COVID-19, in Minas Gerais during the period from 2021 to 2023. A descriptive and quantitative study was carried out, using data secondary, with the calculation of absolute and relative frequencies, measures of central tendency and dispersion, incidence and lethality rates. In 2021, 65,535 cases of SARS were reported in the SIVEP_Gripe system, of which 42,926 (65.5%) were confirmed as COVID-19, resulting in 13,317 deaths. In 2022, 61,712 cases of SARS were recorded, of which 28,108 (45.4%) were confirmed as COVID-19, with 7,487 deaths. In 2023, there were 63,184 cases of SARS, of which 11,909 (18.9%) were confirmed as COVID-19, resulting in deaths. The incidence was 209/100,000, 137/100,000 and 58/100,000, with fatality rates of 31.0%, 28.0% and 18.6% for the years 2021, 2022 and 2023, respectively. The prevalence was higher in males in 2021 and 2023 and in females in 2022, with average ages of 58, 70 and 68 for cases and 67, 77 and 76 for deaths in the years 2021, 2022 and 2023. There was a predominance of white race/color, present in 38.6% to 51.0% of cases and 44.3% to 52.6% of deaths in the same period, in addition to the presence of comorbidities in 67.6% and 86.6% of cases and deaths, respectively. The hospitalization rate was 98.0% and 95.2% for cases and deaths, with 64.3% of patients not requiring ICU and 58.3% of deaths remaining in intensive care. Additionally, 45.6% and 42.4% of cases and deaths received non-invasive ventilatory support, with 78.8% and 87.3% vaccinated against COVID-19. The importance of identifying priority groups, understanding the behavior of the virus in the state and implementing public policies aimed at this specific population is highlighted.
References
Antunes, F. A., Favero, A. P., Scherer, J. de S., Berlese, D. B., & Bueno, A. L. M. (2023). Perfil epidemiológico da síndrome respiratória aguda grave por COVID-19 em idosos. Revista Recien - Revista Científica De Enfermagem, 13(41): 3–12. https://doi.org/10.24276/rrecien2023.13.41.3-12.
Batella, W., & Koiti, M.V. (2020). Relações entre rede urbana e COVID-19 em Minas Gerais. Hygeia., 102–110. https://doi.org/10.14393/Hygeia0054622
Brasil. Ministério da Saúde (2021). Informações da COVID-19. Brasília: Ministério da Saúde. https://www.gov.br/saude/pt-br/coronavirus.
Brasil. Ministério da Saúde (2022). Nota Informativa no 6/2021-CGPNI/DEIDT/SVS/MS. Dispõe sobre as orientações técnicas relativas a continuidade da Campanha Nacional de Vacinação contra a COVID-19. https://www.gov.br/saude/pt-br/assuntos/covid-19/notas-informativas/2021/nota-informativa-no-6-2021-cgpni-deidt-svs-ms.pdf/view.
Brasil. Ministério da Saúde (2024). Secretaria de Vigilância em Saúde e Ambiente. Departamento de Ações Estratégicas de Epidemiologia e Vigilância em Saúde e Ambiente. Guia de vigilância em saúde. Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de Ações Estratégicas de Epidemiologia e Vigilância em Saúde e Ambiente. Brasília: Ministério da Saúde. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/vigilancia/guia-de-vigilancia-em-saude-volume-1-6a-edicao/view.
Brasil. Ministério da Saúde (2022). Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica: emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019 – COVID-19. Ministério da Saúde, Secretaria de Vigilância em Saúde. Brasília: Ministério da Saúde. https://www.gov.br/saude/pt-br/assuntos/covid-19/publicacoes-tecnicas/guias-e-planos/guia-de-vigilancia-epidemiologica-covid-19/view.
Brasil. Ministério da Saúde (2022). SIVEP-Gripe - Sistema De Informação Da Vigilância Epidemiológica Da Gripe Ficha De Registro Individual - Casos De Síndrome Respiratória Aguda Grave Hospitalizado. Disponível em: https://prefeitura.pbh.gov.br/sites/default/files/estrutura-de-governo/saude/2021/ficha_srag_hospitalizado_21.02.2022.pdf.
Brito, S.B.P., Braga, I.O., Cunha, C. C., Palácio, M. A. V. (2020). Pandemia da COVID-19: o maior desafio do século XXI. Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia, 8(2): 54–63.
Candido, D.S., et al. (2020). Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science, 369(6508): 1255–1260. https://doi.org/10.1126/science.abd2161
Carmo, E. H., & Teixeira, M. G. (2021). Vigilância em saúde: preparação, resposta às emergências de saúde pública e o enfrentamento da COVID-19 no Brasil. In C. M. de Freitas (Ed.), COVID-19 no Brasil: cenários epidemiológicos e vigilância em saúde. Série Informação para ação na COVID-19. Fiocruz. https://doi.org/10.7476/9786557081211.0018.
Conselho Nacional de Saúde (CNS). Brasil. Resolução nº 510, de 07 de abril de 2016. https://conselho.saude.gov.br/resolucoes/2016/Reso510.pdf.
De Paiva, C. I., et al. (2020). Perfil epidemiológico da COVID-19 no Estado do Paraná. Revista de Saúde Pública Do Paraná. https://doi.org/10.32811/25954482-2020v3sup1p39.
De Souza G., & Barcelos, C. G. (2021). Incremento no número de casos de síndrome respiratória aguda grave e a sua relação com a COVID-19. Revista Interdisciplinar Ciências Médicas. https://revista.fcmmg.br/index.php/RICM/article/view/121/117.
De Sousa, E. L., et al. (2022). Profile of hospital admissions and deaths due to severe acute respiratory syndrome caused by COVID-19in Piauí, Brazil: a descriptive study, 2020-2021. Epidemiologia e Servicos de Saude : Revista Do Sistema Unico de Saude Do Brasil, 31(1). doi.org/10.1590/S1679-49742022000100009.
De Souza, I.V., Scodro, R. B. L., Siqueira, V. L. D., Cardoso, R. F. & Caleffi-Ferraciolli K. R. (2021). Comorbidades e óbitos por COVID-19 no Brasil. Revista Uningá, 58. doi.org/10.46311/2318-0579.58.eUJ4054.
Dias, J. (2020). COVID-19: relatório apresenta estimativa de infecção pelo vírus no país e os impactos no SUS. Agência Fiocruz de Notícias. https://portal.fiocruz.br/noticia/covid-19-relatorio-apresenta-estimativa-de-infeccao-pelo-virus-no-pais-e-os-impactos-no-sus
https://www.scielo.br/j/rsp/a/798jKxCNGhB85QBJXdK6h9z/?lang=pt#ModalHowcite.
Instituto Brasileiro de Geografia e Estatística (IBGE). (2023). Mapas municipais estatísticos das estimativas populacionais: por cidades e estados. https://www.ibge.gov.br/cidades-e-estados/mg.html.
Merchán-Haman, E. & Tauil, P. L. (2021). Proposta de classificação dos diferentes tipos de estudos epidemiológicos descritivos. Epidemiol. Serv. Saúde. 30 (1) https://doi.org/10.1590/s1679-49742021000100026.
Moura, E. C. et al. (2022). Covid-19: temporal evolution and immunization in the three epidemiological waves, Brazil, 2020–2022. Revista de Saúde Pública, 56(105).
Nico, D., & Maia, L. C. R. (2020). Coronavírus. Arquivos Brasileiros de Medicina Naval, 81(1). https://www.sumarios.org/artigo/coronav%C3%ADrus-hist%C3%B3rico-e-potenciais-vacinas.
Nunes, B. P., et al. (2020). Multimorbidity and population at risk for severe COVID-19 in the Brazilian Longitudinal Study of Aging. Cadernos de Saude Publica, 36(12). https://doi.org/10.1590/0102-311X00129620.
Secretaria de Estado de Saúde de Minas Gerais (SES-MG). (2020). Informe epidemiológico coronavírus. Belo Horizonte: Secretaria de Estado de Saúde de Minas Gerais. https://coronavirus.saude.mg.gov.br/boletim2020.
Silva, G. A. E., Jardim, B. C., & Lotufo, P. A. (2021). Age-adjusted COVID-19 mortality in state capitals in different regions of Brazil. Cadernos de Saude Pública, 37(6). doi.org/10.1590/0102-311X00039221.
Yang J., et al. (2023). Burden of COVID-19 during the omicron predominance in Brazil: a nationwide retrospective database study. J Med Econ., 26(1):1201-1211. doi:10.1080/13696998.2023.2262323.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Deise Aparecida dos Santos; Daniela Aparecida de Faria; Guilherme Pereira Ribeiro; Letícia Aparecida Luciano; Maria Emanuele Azevedo Cirino da Silva; Stefany Cristina dos Santos; Débora Campos Soares Araújo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
